Register now – Nov. 19, 2025: Regulatory compliance and recent policy changes at the federal and state levels relevant to hospital laboratory outreach programs.

Launch or refresh your lab newsletter with five key steps to engage, inform, and build stronger connections with your audience.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss recent news about the use of artificial intelligence (AI) tools in healthcare.

Joseph Yao, M.D., chair of Mayo Clinic’s Division of Clinical Microbiology, joins this episode of the "Answers From the Lab" podcast. Dr. Yao and Bobbi Pritt, M.D., discuss the current status of COVID-19 testing, including tests that can be used to detect variants of the virus.

Top highlights include: Mayo Clinic's response to the Johnson & Johnson COVID-19 vaccine pause, sexually transmitted infections, and should pregnant women be vaccinated for COVID-19?

Dr. Dollahite received world-class cancer treatment from a web of health care organizations, including Mayo Clinic in Rochester, Minnesota. Yet she never left New York; most of her treatment occurred in Ithaca. What made that possible was Cayuga Medical Center’s collaborative relationship with Mayo Clinic. Genetic testing at Mayo Clinic Laboratories provided important information about Dr. Dollahite’s cancer.

For community health care providers, owning a laboratory has been likened to shoveling money down a giant drain. Cayuga Medical Center is challenging that narrative. Instead of selling, Cayuga is investing in its lab — which it considers a value center as well as a key part of patient service.

The pandemic has brought forth extraordinary challenges but also shined a light on the importance of laboratory professionals in health care.

In this episode of Lab Medicine Rounds, Reade Quinton, M.D., discusses what it takes to become a forensic pathologist, talks about common misconceptions related to the field, and describes what a day in the life of a forensic pathologist is like.

Dr. Guenzel, a fellow in Laboratory Genetics and Genomics at Mayo Clinic, is the recipient of this award for his publication “The critical role of psychosine in screening, diagnosis, and monitoring of Krabbe disease.”

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., discuss vaccine passports. They review how proof of vaccination could be used along with other tools, like testing, to help curb the spread of COVID-19.

Based on studies that have shown certain antibodies may not be as clinically relevant to autoimmune testing as previously thought, Mayo Clinic Laboratories is updating a number of its autoimmune profiles by removing some antibodies from them.

This week’s research roundup features a study on noncanonical AR addiction that drives enzalutamide resistance in prostate cancer.

Christopher Klein, M.D., discusses Mayo Clinic’s updated myasthenia gravis and Lambert-Eaton syndrome testing approach. Automatic reflex to second-line testing saves time and increases sensitivity and specificity to confirm diagnosis in patients with atypical presentation.

Top highlights include: Lessons learned in addressing global health equity, updates on traveling during the pandemic, and optimism along with concerns about the fourth wave of infections.